English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Different approaches have been used in the di-agnosis of chronic Chagas disease. Serologic testsare used to detect antibodies against Trypanosomacruzi and not the presence of the parasite itself.These tests have high sensitivity but lack specific-ity because of antigenic cross-reactivity with para-sites such as Leishmania sp. and T. rangeli(Schmunis 1991, Saldana & Sousa 1996). Parasi-tological tests such as hemoculture or xenodiag-nosis have proven to be highly specific, but thesensitivity of these techniques is low. Recently,molecular assays such as the polymerase chain re-action (PCR), which amplify certain repetitive se-quences of trypanosome kinetoplast DNA (kDNA)have been proposed as a good alternative too fordetection of T. cruzi in human blood (Avila et al.1993, Wincker et al. 1994, Britto et al. 1995a). The≈330-base pair (bp) fragment of the kinetoplastminicircles is normally used as a target for ampli-fication.The PCR assay has shown a variable degree ofefficiency. Initial sensitivity reports ranged from96% to 100% compared with serologic diagnosis(Avila et al. 1993, Wincker et al. 1994). A lowersensitivity level was observed by different research-ers (Britto et al. 1995b, Junqueira et al. 1996).These inconsistencies illustrate the need for addi-tional evaluation of large numbers of chagasic in-dividuals from different endemic regions in Brazildue to extensive variations in the incidence andclinical manifestations of Chagas disease in thiscountry.A new technique to verify cure in chagasic pa-tients who received specific treatment is needed.Conventional serologic tests such as the indirectimmunofluorescence (IIF) test, the indirect hemag-glutination test, and the ELISA are ineffective be-cause they are persistently positive in most treated

Chagas disease diagnosis using polymerase chain reaction, hemoculture and serologic methods